Document is current
Any future updates will be listed below
-
Authors
,
Pasquau, Juan https://orcid.org/0000-0001-9409-9205
de Jesus, Samantha E.
Arazo, Piedad
Crusells, María J.
Ríos, María J.
Lozano, Fernando
de la Torre, Javier
Galindo, María J.
Carmena, Jorge
Santos, Jesús
Tornero, Carlos
Verdejo, Guillermo
Samperiz, Gloria
Palacios, Zaira
Hidalgo-Tenorio, Carmen
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals (930034_IIS)
- License Information
-
More Information
Article History
Received: 18 November 2018
Accepted: 13 February 2019
First Online: 28 February 2019
Competing interest
: JP has received financial grants and/or honoraria from Janssen-Cilag, ViiV Healthcare, Bristol-Myers-Squibb, Merck Sharp & Dohme, Gilead & Abbvie as speaker fees and/or as Advisor fees. PA has received honoraria from Abbvie, Bristol-Myers Squibb, Gilead, Janssen, Merck and ViiV Healthcare as speaker fees and/or advisor fees as well as compensation for writing manuscripts and developing educational presentations. MJC has received honoraria from Abbvie, Gilead, Janssen, Merck and ViiV Healthcare as speaker fees and/or advisor fees. FL has received financial grants and/or honoraria from Gilead, Janssen, Merck and ViiV Healthcare as speaker fees. JdT has received honoraria from Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen, Merck, Boehringer-Ingelheim and ViiV Healthcare as speaker fees and/or advisory fees. JS has received honoraria from Janssen, ViiV Healthcare, Merck and Gilead as speaker fees and/or advisory fees. ZP has received speaker honoraria from Gilead. Rest of authors have no conflicts of interest to declare.
: The study was approved by the regional ethics committee of Andalusia (CCEIBA) on April 25, 2016 and participants provided written informed consent for data from their medical records to be collected.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
